Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
3.
Yaoxue Xuebao ; 58(1):39-51, 2023.
Article in Chinese | Scopus | ID: covidwho-2269131
4.
14th International Conference on Education Technology and Computers, ICETC 2022 ; : 350-355, 2022.
Article in English | Scopus | ID: covidwho-2287283
5.
Latin American Journal of Pharmacy ; 41(11), 2022.
Article in English | Web of Science | ID: covidwho-2243088
6.
Yaoxue Xuebao ; 58(1):39-51, 2023.
Article in Chinese | EMBASE | ID: covidwho-2242735
7.
Yaoxue Xuebao ; 58(1):39-51, 2023.
Article in English | Scopus | ID: covidwho-2242734
8.
International Journal of Rheumatic Diseases ; 26(Supplement 1):375.0, 2023.
Article in English | EMBASE | ID: covidwho-2237321

ABSTRACT

Background: Under the current situation of COVID-19 pandemic, more medical resources are assigned to the prevention and control of the pandemic, while relatively less attention is paid to patients with chronic diseases. Previous studies reported that COVID-19 deaths were mainly observed among male patients with multiple comorbidities, and the major comorbidities were hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis, all of which are chronic diseases. As one of the most common chronic diseases that occurs in male, no report regarding how COVID-19 impacts gout patients psychologically due to the general susceptibility, their mental state and willingness to adhere to ULT treatment and the actual ULT adherence so far. This study aims to assess urate-lowering therapy adherence and the relationship with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients during the COVID-19 outbreak. Method(s): The cross-sectional study employed a total of 101 gout patients receiving urate-lowering therapy to evaluate adherence, medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern via a mobile app-based questionnaire. Statistical analysis was performed using SPSS 22.0. Result(s): 101 valid responses were included in the statistical analysis. Patients' adherence rate to urate-lowering therapy during the COVID-19 outbreak was 22.8%, higher than that in normal periods (9.6%). Compared with adherent groups, non-adherent gout patients had shorter disease duration, lower self-efficacy, lower Necessity about urate-lowering therapy score, higher Concerns about urate-lowering therapy score, and smaller Necessity-Concerns differential. Depression and anxiety rates (3.0% and 5.0%, respectively) during the COVID-19 break were lower than that in normal periods. Additionally, depression, anxiety, as well as COVID-19 pandemic-related concern (27.7%) were not related to ULT adherence. Conclusion(s): Adherence rate to urate-lowering therapy in Chinese gout patients during the COVID-19 outbreak was 13.2%, higher than normal times, but still very poor. Except for a little concern about being more susceptible to the virus, patients' mental state is relatively good. While the country puts great efforts in COVID-19 prevention and control, attention must also be paid to the medication management of patients with chronic diseases such as gout.

9.
Yaoxue Xuebao ; 58(1):39-51, 2023.
Article in Chinese | Scopus | ID: covidwho-2232554

ABSTRACT

Since the outbreak of the novel coronavirus (SARS-CoV-2) disease COVID-19 (also known as 2019-nCoV) caused by SARS-CoV-2 in the end of 2019, it has spread rapidly in worldwide. Besides developing effective vaccines, it is urgent to develop safe and effective anti-SARS-CoV-2 drugs to fight this disease. Paxlovid, molnupiravir, sotrovimab and bebtelovimab are urgently authorized by FDA have been proved to be effective against Omicron. This manuscript mainly reviews the recent progress of effective inhibitors against the virus in the world, including receptor inhibitors, antibodies, natural product inhibitors, synthetic inhibitors and broad-spectrum antiviral drugs that are effective against other RNA viruses. © 2023, Chinese Pharmaceutical Association. All rights reserved.

10.
IEEE Journal on Selected Areas in Communications ; : 1-1, 2022.
Article in English | Scopus | ID: covidwho-2097636
13.
Journal of General Internal Medicine ; 37:S624-S625, 2022.
Article in English | EMBASE | ID: covidwho-1995865
14.
47th IEEE International Conference on Acoustics, Speech, and Signal Processing, ICASSP 2022 ; 2022-May:1376-1380, 2022.
Article in English | Scopus | ID: covidwho-1891395
15.
Multiple Sclerosis Journal ; 28(1_SUPPL):155-156, 2022.
Article in English | Web of Science | ID: covidwho-1865889
16.
INFORMS International Conference on Service Science, ICSS 2020 ; : 367-379, 2022.
Article in English | Scopus | ID: covidwho-1750469
18.
Fortschritte Der Neurologie Psychiatrie ; 89(12):602-603, 2021.
Article in German | Web of Science | ID: covidwho-1576116
19.
Female Pelvic Medicine and Reconstructive Surgery ; 27(10 SUPPL 1):S126, 2021.
Article in English | EMBASE | ID: covidwho-1511128
SELECTION OF CITATIONS
SEARCH DETAIL